C
TransMedics Group, Inc. TMDX
$125.28 -$3.22-2.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 37.68% 48.21% 49.83% 63.72% 117.87%
Total Other Revenue -- -- -- -- --
Total Revenue 37.68% 48.21% 49.83% 63.72% 117.87%
Cost of Revenue 34.94% 49.94% 49.21% 85.95% 186.47%
Gross Profit 39.46% 47.14% 50.27% 49.64% 88.51%
SG&A Expenses 2.78% 20.64% 44.06% 39.16% 46.12%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 18.67% 37.50% 47.55% 55.19% 90.73%
Operating Income 192.35% 120.94% 87.79% 449.33% 1,480.57%
Income Before Tax 197.72% 115.25% 80.92% 115.76% 1,340.10%
Income Tax Expenses 3,209.76% 407.14% 178.57% 101.92% -295.24%
Earnings from Continuing Operations 186.26% 110.56% 70.11% 116.58% 1,318.18%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 186.26% 110.56% 70.11% 116.58% 1,318.18%
EBIT 192.35% 120.94% 87.79% 449.33% 1,480.57%
EBITDA 153.10% 100.80% 74.51% 1,081.82% 3,419.96%
EPS Basic 179.55% 104.57% 65.26% 116.18% 1,295.45%
Normalized Basic EPS 190.80% 109.14% 15.76% 1,368.52% 1,319.68%
EPS Diluted 162.49% 100.63% 76.83% 115.38% 1,236.36%
Normalized Diluted EPS 159.11% 86.97% 15.76% 1,277.78% 1,244.68%
Average Basic Shares Outstanding 2.39% 2.93% 2.90% 2.54% 1.76%
Average Diluted Shares Outstanding 14.94% 15.10% 3.02% 9.41% 8.43%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --